Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

Journal of Experimental Medicine

Volumn 187, Issue 12, 1998, Pages 2037-2044

  Wekerle, Thomas ^a   Sayegh, Mohamed H ^b   Hill, Joshua ^a   Zhao, Yong ^a   Chandraker, Anil ^b   Swenson, Kirsten G ^a   Zhao, Guiling ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone marrow; Chimerism; Costimulation; Tolerance; Transplantation

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; WHOLE BODY RADIATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL LINEAGE; CLONAL DELETION; GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOCONJUGATES; MEMBRANE GLYCOPROTEINS; MICE; RADIATION CHIMERA; SKIN TRANSPLANTATION;

EID: 0032526283     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.12.2037     Document Type: Article

References (45)

1. Gjertson, D.W. 1991. Survival trends in long-term first cadaver-donor kidney transplants. In Clinical Transplants. P.I. Terasaki and J.M. Cecka, editors. UCLA Tissue Typing Laboratory, Los Angeles. 225-235.
2. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
3. Sayegh, M.H., E. Akalin, W.W. Hancock, M.E. Russell, C.U. Carpenter, P.S. Linsley, and L.A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869-1874.
4. Foy, T.M., A. Aruffo, J. Bajorath, J.E. Buhlmann, and R.J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591-617.
5. Hancock, W.W., M.H. Sayegh, R. Peach, P.S. Linsley, and L.A. Turka. 1996. Costimulatory function of CD40L, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA. 93:13967-13972.
6. Larsen, C.P., and T.C. Pearson. 1997. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr. Opin. Immunol. 9:641-647.
7. Lenshow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islets induced by CTLA4Ig. Science. 257:789-792.
8. Pearson, T.C., D.Z. Alexander, K.J. Winn, P.S. Linsley, R.P. Lowry, and C.P. Larsen. 1994. Transplantation tolerance induced by CTLA4Ig. Transplantation. 57:1701-1706.
9. Markees, T.G., N.E. Phillips, R.J. Noelle, L.D. Shultz, J.P. Mordes, D.L. Greiner, and A.A. Rossini. 1997. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation. 64:329-335.
10. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 257:792-795.
11. Larsen, C.P., E.T. Elwood, D.Z. Alexander, S.C. Ritchie, R. Hendrix, C. Tucker-Burden, H. Rae Cho, A. Aruffo, D. Hollenbaugh, P.S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
12. Kirk, A.D., D.M. Harlan, N.N. Armstrong, T.A. Davis, Y. Dong, G.S. Gray, X. Hong, D. Thomas, J.H. Fechner, Jr., and S.J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA. 94:8789-8794.
13. Sayegh, M.H., and L.A. Turka. 1998. The role of T cell costimulatory activation pathways in transplant rejection. N. Engl. J. Med. In press.
14. Sykes, M. 1996. Chimerism and central tolerance. Curr. Opin. Immunol. 8:694-703.
15. Nossal, G.J.V. 1994. Negative selection of lymphocytes. Cell. 76:229-239.
16. Billingham, R.E., L. Brent, and P.B. Medawar. 1953. "Actively acquired tolerance" of foreign cells. Nature. 172:603-606.
17. Sykes, M., M.L. Romick, K.A. Hoyles, and D.H. Sachs. 1990. In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment. J. Exp. Med. 171: 645-658.
18. Sharabi, Y., and D.H. Sachs. 1989. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J. Exp. Med. 169:493-502.
19. Miller, J.F.A.P. 1960. Studies on mouse leukaemia: the role of the thymus in leukaemagenesis by cell-free leukemic infiltrates. Br. J. Cancer. 14:93-97.
20. Sykes, M., M.W. Harty, F.M. Karlhofer, D.A. Pearson, G. Szot, and W. Yokoyama. 1993. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J. Exp. Med. 178:223-229.
21. Tomita, Y., D.H. Sachs, A. Khan, and M. Sykes. 1996. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation. 61:469-477.
22. Unkeless, J.C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580-596.
23. Tomita, Y., A. Khan, and M. Sykes. 1994. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J. Immunol. 153:1087-1098.
24. Tomita, Y., A. Khan, and M. Sykes. 1996. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation. 61:477-485.
25. Ildstad, S.T., and D.H. Sachs. 1984. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 307: 168-170.
26. Nomoto, K., K. Yung-Yun, K. Omoto, M. Umesue, Y. Murakami, and G. Matsuzaki. 1995. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-αβ monoclonal antibody, low dose irradiation, and donor bone marrow transfusion. Transplantation. 59:395-401.
27. Colson, Y.L., H. Li, S.S. Boggs, K.D. Patrene, P.C. Johnson, and S.T. Ildstad. 1996. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J. Immunol. 157:2820-2829.
28. Mayumi, H., and R.A. Good. 1989. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J. Exp. Med. 169:213-238.
29. Mackall, C.L., T.A. Fleisher, M.K. Brown, M.P. Andrich, C.C. Chen, I.M. Feuerstein, M.E. Horowitz, I.T. Magrath, A.T. Shad, S.M. Steinberg, et al. 1995. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143-149.
30. Konieczny, B.T., Z. Dai. E.T. Elwood, S. Saleem, P.S. Linsley, F.K. Baddoura, C.P. Larsen, T.C. Pearson, and F.G. Lakkis. 1998. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160:2059-2064.
31. Acha-Orbea, H., and E. Palmer. 1991. Mls - a retrovirus exploits the immune system. Immunol. Today. 12:356-361.
32. Tomonari, K., and S. Fairchild. 1991. The genetic basis of negative selection of Tcrβ-V11β+ T cells. Immunogenetics. 33:157-162.
33. Dyson, P.J., A.M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature. 349:531-532.
34. Bill, J., O. Kanagawa, D. Woodland, and E. Palmer. 1989. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of Vβ11-bearing T cells. J. Exp. Med. 169: 1405-1419.
35. Foy, T.M., D.M. Shepherd, F.H. Durie, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567-1575.
36. Van den Eertwegh, A.J.M., R.J. Noelle, M. Roy, D.M. Shepherd, A. Aruffo, J.A. Ledbetter, W.J. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178:1555-1565.
37. Tomita, Y., D.H. Sachs, and M. Sykes. 1994. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood. 83:939-948.
38. Webb, S.R., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
39. Kawabe, Y., and A. Ochi. 1991. Programmed cell death and extrathymic reduction in Vβ8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245-248.
40. L. Immunity. 3:87-98.
41. Noel, P.J., L.H. Boise, J.M. Green, and C.B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636-642.
42. Radvanyi, L.G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G.B. Mills, and R.D. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788-1798.
43. a-encoded antigens. J. Exp. Med. 167: 2005-2010.
44. + T cells expressing Vβ11 receptors to respond to I-E alloantigens in vivo. J. Exp. Med. 170: 1947-1957.
45. Parker, D.C., D.L. Greiner, N.E. Phillips, M.C. Appel, A.W. Steele, F.H. Durie, R.J. Noelle, J.P. Mordes, and A.A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA. 92:9560-9564.